Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 27.80M | £ 25.90M | £ 20.80M | £ 28.80M | £ 59.80M |
Total Assets | £ 706.50M | £ 681.30M | £ 578.10M | £ 508.70M | £ 461.50M |
Total Debt | £ 223.70M | £ 228.10M | £ 216.70M | £ 164.40M | £ 116.90M |
Net Debt | £ 195.90M | £ 202.20M | £ 195.90M | £ 135.60M | £ 57.10M |
Total Liabilities | £ 636.10M | £ 617.70M | £ 563.10M | £ 510.40M | £ 489.90M |
Stockholders Equity | £ 70.40M | £ 63.60M | £ 15.00M | £ -1.70M | £ -28.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |